Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastoma
- Journal:
- Nature Communications
- Published:
- Affiliations:
- 5
- Authors:
- 20
| Institutions | Authors | Share |
|---|---|---|
| Xiamen University (XMU), China | 0.48 | |
| State Key Laboratory of Vaccines for Infectious Diseases, XMU, China | 0.43 | |
| The First Affiliated Hospital of Xiamen University, China | 0.08 | |
| The Seventh Affiliated Hospital, SYSU, China | 0.03 |